FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T22:35:38.822Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T22:35:38.822Z. Latest historical point 2024-04-09. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T22:35:38.822Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T22:35:38.822Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T22:35:38.822Z. Latest historical point 2024-04-09. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T22:35:38.822Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T22:35:38.822Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
Product / business disclosures (FY 2024)
2024-05-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Med Device$197.51M
Med Tech$106.40M
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Geographic disclosures (FY 2026)
2026-05-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$86.61M
vs Estimate
$80.24M
Beat
ANGO Analyst Ratings
Consensus Rating
Buy
Based on 4 analysts
Strong Buy
0
Buy
4
Hold
0
Sell
0
Strong Sell
0
Average Price Target
$20.00
+38.7% upside
Low
$17.00
Current
$14.42
High
$24.00
ANGO Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
Period
Low
Avg
High
# Analysts
Quarter ending Aug 2026
$-0.12
$-0.11
$-0.10
2
Quarter ending Nov 2026
$-0.09
$-0.08
$-0.07
2
Quarter ending Feb 2027
$-0.06
$-0.06
$-0.06
1
Quarter ending May 2027
$-0.01
$-0.01
$-0.01
1
Annual
Period
Low
Avg
High
# Analysts
FY 2027
$-0.28
$-0.27
$-0.25
2
FY 2028
$-0.05
$-0.04
$-0.04
2
Revenue Estimates
Quarterly
Period
Low
Avg
High
# Analysts
Quarter ending Aug 2026
$80.44M
$80.51M
$80.57M
3
Quarter ending Nov 2026
$83.82M
$83.98M
$84.13M
3
Quarter ending Feb 2027
$82.57M
$83.69M
$84.43M
1
Quarter ending May 2027
$87.78M
$88.98M
$89.77M
1
Annual
Period
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.